Welcome to our dedicated page for Cre8 Enterprise, Ltd. news (Ticker: CRE), a resource for investors and traders seeking the latest updates and insights on Cre8 Enterprise, Ltd. stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Cre8 Enterprise, Ltd.'s stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Cre8 Enterprise, Ltd.'s position in the market.
Cre8 Enterprise Ltd. (NASDAQ: CRE) has successfully completed its Initial Public Offering (IPO) with American Trust Investment Services (ATIS) as the lead underwriter. The Hong Kong-based company offered 1,450,000 Class A ordinary shares at $4.00 per share, raising approximately $5.8 million in gross proceeds.
Founded in 2006, Cre8 Enterprise is a provider of integrated financial printing and disclosure services, serving Hong Kong-listed companies and IPO applicants. The company plans to use the proceeds to enhance its regulatory technology platform, improve printing and logistics capacity, and for general corporate purposes.
Cre8 Enterprise Limited (Nasdaq: CRE), a Hong Kong-based financial printing service provider, has announced the pricing of its initial public offering of 1,450,000 Class A ordinary shares at $4.00 per share. The company expects to raise gross proceeds of approximately $5.8 million from the offering.
Trading is set to commence on the Nasdaq Capital Market on July 23, 2025, under the symbol "CRE". The underwriters have a 45-day option to purchase up to 217,500 additional shares. The company plans to use the proceeds for upgrading its Hong Kong office, business expansion, workforce development, IT systems enhancement, and working capital.